Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4204-4207

  Goan, Yih Gang ^a   Zhou, Bingsen ^b   Hu, Edward ^b   Mi, Shu ^b   Yen, Yun ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; MESSENGER RNA; RIBONUCLEOTIDE REDUCTASE;

AMINO ACID SEQUENCE; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYADENINE NUCLEOTIDES; DEOXYCYTIDINE; DEOXYCYTOSINE NUCLEOTIDES; DRUG RESISTANCE, NEOPLASM; HUMANS; KB CELLS; RIBONUCLEOTIDE REDUCTASES;

EID: 0033198464     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Guchelaar, H. J., Richel, D. J., and van Knapen, A. Clinical, toxicological and pharmacological aspects of gemcitabine. Cancer Treat. Rev., 22: 15-31, 1983.
2. Plunkett, W., Huang, P., Xu, Y. Z., Heinemann, V., Grunewald, R., and Gandhi, V. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin. Oncol., 22 (Suppl. 11): 3-10, 1995.
3. Heinemann, V., Hertel, L. W., Grindey, G. B., and Plunkett, W. Comparison of the cellular pharmacokinetics and toxicity of 2,2-difluorodeoxycytidine and 1-β-D-arabinofuranosylcytosine. Cancer Res., 48: 4024-4031, 1988.
4. Cory, J. G., and Sato, A. Regulation of ribonucleotide reductase activity in mammalian cells. Mol. Cell. Biochem., 53: 257-266, 1983.
5. Thelander, L., and Berg, P. Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase. Mol. Cell. Biol., 6: 3433-3422, 1986.
6. Zhou, B. S., Tsai, P., Ker, R., Tsai, J., Ho, R., Yu, J., Shih, J., and Yen, Y. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhance their invasion potential. Clin. Exp. Metastasis, 16: 43-49, 1998.
7. Fan H., Villegas, C., and Wright, J. A. Ribonucleotide reductase R2 component is a novel malignancy determination that cooperates with activated oncogenes to determine transformation and malignant potential. Proc. Natl. Acad. Sci. USA, 93: 14036-14040, 1996.
8. Hertel, L. W., Boder, G. B., Kroin, J. S., Rinzel, S. M., Poore, G. A., Todd, G. C., and Grindey, G. B. Evaluation of the antitumor activity of gemcitabine (2,2-difluoro-2-deoxycytidine). Cancer Res., 50: 4417-4422, 1990.
9. Braakhuis, B. J. M., Van Dongen, G. A. M. S., Vermorken, J. B., and Snow, G. B. Preclinical in vivo activity of 2,2-difluorodeoxycytidine (gemcitabine) against human head and neck cancer. Cancer Res., 51: 211-214, 1991.
10. Ruiz van Haperen V. W. T., Veerman, G., Eriksson, S., Boven, E., Stegmann, A. P. A., Hermsen, M., Vermorken, J. B., Pinedo, H. M., and Peters, G. J. Development and molecular characterization of a 2, 2-difluorodeoxycytidine resistant variant of the human ovarian carcinoma cell line A2780. Cancer Res., 54: 4138-4143, 1994.
11. Bhalla, K., Nayak, R., and Grant, S. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res., 44: 5029-5037, 1984.
12. Wiley, J. S., Jones, S. P., Sawyer, W. H., and Paterson, A. R. P. 1-β-D-arabinofuranosylcytosine influx and nucleoside transport sites in acute leukemia. J. Clin. Invest., 69: 479-489, 1982.
13. Chan, T. C. K., Augmentation of 1-β-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux. Cancer Res., 49: 2656-2660, 1989.
14. Yen, Y., Grill, S. P., Dutschman, G. E., Chang, C. N., Zhou, B. S., and Cheng, Y. C. Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine. Cancer Res., 54: 3686-3691, 1994.
15. Zhou, B. S., Hsu, N. Y., Pan, B. C., Doroshow, J. H., and Yen, Y. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells. Cancer Res., 55: 1328-1333, 1995.
16. Zhou, B. S., Ker, R., Ho, R., Yu J., Zhao, Y. R., Shih, J., and Yen, Y. Determination of deoxyribonucleoside triphosphate pool size in ribonucleotide reductase cDNA transfected human KB cells. Biochem. Pharmacol., 55: 1657-1665, 1998.
17. Steeper, J. P., and Stuart, C. D. A rapid assay for CDP reductase activity in mammalian cell extracts. Anal. Biochem., 34: 123-130, 1970.
18. Ivies, D. H., Durhan, J. P., and Tucker, V. S. Rapid determination of nucleoside kinase and nucleotidase activities with tritium-labeled substrates. Anal. Biochem., 28: 192-205, 1968.
19. Bradford, M. A. A rapid and sensitive method for the qualification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
20. Ruiz van Haperen, V. M. T., Veerman, G., van Moorsel, C. T. A., and Peters, G. J. Induction of in vivo resistance against gemcitabine. Adv. Exp. Med. Biol., 431: 637-640, 1998.